Literature DB >> 29390153

Interleukin-21 Regulates Natural Killer Cell Responses During Mycobacterium tuberculosis Infection.

Padmaja Paidipally1, Deepak Tripathi1, Abhinav Van1, Rajesh Kumar Radhakrishnan1, Rohan Dhiman1, Sambasivan Venkatasubramanian1, Kamakshi P Devalraju2, Amy R Tvinnereim1, Vijaya Lakshmi Valluri2, Ramakrishna Vankayalapati1.   

Abstract

Background: In the current study, we determined the effects of interleukin (IL)-21 on human natural killer (NK) cells and monocyte responses during Mycobacterium tuberculosis (Mtb) infection.
Methods: We found that Mtb stimulated CD4+ and NK T cells from healthy individuals with latent tuberculosis infection (LTBI+) are major sources of IL-21. CD4+ cells from tuberculosis patients secreted less IL-21 than did CD4+ cells from healthy LTBI+ individuals. Interleukin-21 had no direct effect on Mtb-stimulated monocytes.
Results: Interleukin-21-activated NK cells produced interferon (IFN)-γ, perforin, granzyme B, and granulysin; lysed Mtb-infected monocytes; and reduced Mtb growth. Interleukin-21-activated NK cells also enhanced IL-1β, IL-18, and CCL4/macrophage-inflammatory protein (MIP)-1β production and reduced IL-10 production by Mtb-stimulated monocytes. Recombinant IL-21 (1) inhibited Mtb growth, (2) enhanced IFN-γ, IL-1β, IL-18, and MIP-1β, and (3) reduced IL-10 expression in the lungs of Mtb-infected Rag2 knockout mice. Conclusions: These findings suggest that activated T cells enhance NK cell responses to lyse Mtb-infected human monocytes and restrict Mtb growth in monocytes through IL-21 production. Interleukin-21-activated NK cells also enhance the immune response by augmenting IL-1β, IL-18, and MIP-1β production and reducing IL-10 production by monocytes in response to an intracellular pathogen.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29390153      PMCID: PMC6018723          DOI: 10.1093/infdis/jiy034

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  48 in total

Review 1.  Immunology of tuberculosis.

Authors:  J L Flynn; J Chan
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

2.  HIV-1-specific interleukin-21+ CD4+ T cell responses contribute to durable viral control through the modulation of HIV-specific CD8+ T cell function.

Authors:  Mathieu F Chevalier; Boris Jülg; Augustine Pyo; Michael Flanders; Srinika Ranasinghe; Damien Z Soghoian; Douglas S Kwon; Jenna Rychert; Jeffrey Lian; Matthias I Muller; Sam Cutler; Elizabeth McAndrew; Heiko Jessen; Florencia Pereyra; Eric S Rosenberg; Marcus Altfeld; Bruce D Walker; Hendrik Streeck
Journal:  J Virol       Date:  2010-11-03       Impact factor: 5.103

3.  Immunology. A chronic need for IL-21.

Authors:  Lisa D S Johnson; Stephen C Jameson
Journal:  Science       Date:  2009-06-19       Impact factor: 47.728

4.  Production of interleukin-18 in human tuberculosis.

Authors:  R Vankayalapati; B Wizel; S E Weis; B Samten; W M Girard; P F Barnes
Journal:  J Infect Dis       Date:  2000-06-29       Impact factor: 5.226

5.  Beta-chemokines are induced by Mycobacterium tuberculosis and inhibit its growth.

Authors:  Jussi J Saukkonen; Beth Bazydlo; Michael Thomas; Robert M Strieter; Joseph Keane; Hardy Kornfeld
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

6.  Interleukin 22 inhibits intracellular growth of Mycobacterium tuberculosis by enhancing calgranulin A expression.

Authors:  Rohan Dhiman; Sambasivan Venkatasubramanian; Padmaja Paidipally; Peter F Barnes; Amy Tvinnereim; Ramakrishna Vankayalapati
Journal:  J Infect Dis       Date:  2013-09-16       Impact factor: 5.226

7.  NK cells lyse T regulatory cells that expand in response to an intracellular pathogen.

Authors:  Sugata Roy; Peter F Barnes; Ankita Garg; Shiping Wu; David Cosman; Ramakrishna Vankayalapati
Journal:  J Immunol       Date:  2008-02-01       Impact factor: 5.422

Review 8.  Interleukin-21: a new modulator of immunity, infection, and cancer.

Authors:  Katja Brandt; Prim B Singh; Silvia Bulfone-Paus; René Rückert
Journal:  Cytokine Growth Factor Rev       Date:  2007-05-16       Impact factor: 7.638

9.  Decreased frequencies of circulating CD4⁺ T follicular helper cells associated with diminished plasma IL-21 in active pulmonary tuberculosis.

Authors:  Nathella Pavan Kumar; Rathinam Sridhar; Luke E Hanna; Vaithilingam V Banurekha; Thomas B Nutman; Subash Babu
Journal:  PLoS One       Date:  2014-10-24       Impact factor: 3.240

Review 10.  The γ c family of cytokines: fine-tuning signals from IL-2 and IL-21 in the regulation of the immune response.

Authors:  Rosanne Spolski; Daniel Gromer; Warren J Leonard
Journal:  F1000Res       Date:  2017-10-23
View more
  7 in total

1.  IL-21/IL-21R Regulates the Neutrophil-Mediated Pathologic Immune Response during Chlamydial Respiratory Infection.

Authors:  Jiajia Zeng; Yueyue Xu; Lu Tan; Xiaoyu Zha; Shuaini Yang; Hong Zhang; Yuqing Tuo; Ruoyuan Sun; Wenhao Niu; Gaoju Pang; Lida Sun; Hong Bai
Journal:  Mediators Inflamm       Date:  2022-06-01       Impact factor: 4.529

2.  Exploiting Pre-Existing CD4+ T Cell Help from Bacille Calmette-Guérin Vaccination to Improve Antiviral Antibody Responses.

Authors:  Tony W Ng; Ariel S Wirchnianski; Anna Z Wec; J Maximilian Fels; Christopher T Johndrow; Kevin O Saunders; Hua-Xin Liao; John Chan; William R Jacobs; Kartik Chandran; Steven A Porcelli
Journal:  J Immunol       Date:  2020-06-08       Impact factor: 5.422

Review 3.  RNA Sensing of Mycobacterium tuberculosis and Its Impact on TB Vaccination Strategies.

Authors:  Sanne Burkert; Ralf R Schumann
Journal:  Vaccines (Basel)       Date:  2020-02-04

4.  A Bovine Enteric Mycobacterium Infection Model to Analyze Parenteral Vaccine-Induced Mucosal Immunity and Accelerate Vaccine Discovery.

Authors:  Antonio Facciuolo; Amy H Lee; Michael J Trimble; Neil Rawlyk; Hugh G G Townsend; Manjeet Bains; Natasa Arsic; Lucy M Mutharia; Andrew Potter; Volker Gerdts; Scott Napper; Robert E W Hancock; Philip J Griebel
Journal:  Front Immunol       Date:  2020-11-23       Impact factor: 7.561

5.  Evaluation of early innate and adaptive immune responses to the TB vaccine Mycobacterium bovis BCG and vaccine candidate BCGΔBCG1419c.

Authors:  Manuja Gunasena; Rajni Kant Shukla; Naiquan Yao; Oscar Rosas Mejia; Michael D Powell; Kenneth J Oestreich; Michel de Jesús Aceves-Sánchez; Mario Alberto Flores-Valdez; Namal P M Liyanage; Richard T Robinson
Journal:  Sci Rep       Date:  2022-07-20       Impact factor: 4.996

Review 6.  Thinking Outside the Box: Innate- and B Cell-Memory Responses as Novel Protective Mechanisms Against Tuberculosis.

Authors:  José Alberto Choreño-Parra; León Islas Weinstein; Edmond J Yunis; Joaquín Zúñiga; Rogelio Hernández-Pando
Journal:  Front Immunol       Date:  2020-02-14       Impact factor: 7.561

7.  T helper type cytokines in sepsis: time-shared variance and correlation with organ dysfunction and hospital mortality.

Authors:  Ramon Teixeira Costa; Orlei Ribeiro de Araújo; Milena Karina Coló Brunialti; Murilo Santucci Cesar Assunção; Luciano César Pontes Azevedo; Flávio Freitas; Reinaldo Salomão
Journal:  Braz J Infect Dis       Date:  2019-05-18       Impact factor: 3.257

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.